Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)

RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position. In a recent filing with the Securities and Exchange Commission, Mintz’s fund, Sabby Capital, has reported ownership of 575,000 shares, which account for 7.31% of the total number of shares outstanding.

RiceBran Technologies (NASDAQ:RIBT)

No other hedge funds that we track hold RiceBran Technologies (NASDAQ:RIBT) in their portfolio. The company completed a public offering on June 26.  A total of 1,417,500 shares of common stock were offered at a price of $5.29 apiece, with estimated gross proceeds of $7.5 million. The underwriters were awarded options for another 708,750 shares as over-allotments. The company plans to use the proceeds to pay off some of the debt and for working capital needs for its operation in the United States and Brazil.

RiceBran Technologies (NASDAQ:RIBT), formerly known as NutraCea, is a nutrition company, marketing products derived from rice bran. The company has a market cap of $16 million and does not pay a dividend. So far this year, the stock has been oscillating around the $5 level and is currently traded at $5.25 per share. For the three months ending March 31, 2014, RiceBran Technologies posted $7.68 million in revenues and a loss per share of $0.62.

In a recent move, Mintz has initiated a significant new position in Brainstorm Cell Therapeutics Inc (OTCBB:BCLI). Sabby Capital has reported ownership of 22 million shares or 9.79% of the company’s common stock. Another new addition to Sabby’s equity portfolio is Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV): 9.11 million shares. Mintz is also optimistic about the prospects of Bio-Path Holdings Inc (NASDAQ:BPTH), having increased his fund’s stake to 4.45 million shares, which gives him control over 4.9% of the company’s common stock. The fund’s top position continues to be Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), despite the fact that Mintz has reduced it by 21% to approximately 364,750 shares during the first quarter of 2014.

Disclosure: none.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!